132 related articles for article (PubMed ID: 22446059)
1. Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease.
Fernandes VS; Santos JR; Leão AH; Medeiros AM; Melo TG; Izídio GS; Cabral A; Ribeiro RA; Abílio VC; Ribeiro AM; Silva RH
Behav Brain Res; 2012 May; 231(1):154-63. PubMed ID: 22446059
[TBL] [Abstract][Full Text] [Related]
2. Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine.
Santos JR; Cunha JA; Dierschnabel AL; Campêlo CL; Leão AH; Silva AF; Engelberth RC; Izídio GS; Cavalcante JS; Abílio VC; Ribeiro AM; Silva RH
Behav Brain Res; 2013 Sep; 253():68-77. PubMed ID: 23831411
[TBL] [Abstract][Full Text] [Related]
3. Effects of reserpine on the plus-maze discriminative avoidance task: dissociation between memory and motor impairments.
Carvalho RC; Patti CC; Takatsu-Coleman AL; Kameda SR; Souza CF; Garcez-do-Carmo L; Abílio VC; Frussa-Filho R; Silva RH
Brain Res; 2006 Nov; 1122(1):179-83. PubMed ID: 17030027
[TBL] [Abstract][Full Text] [Related]
4. Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rats (SHR): Implications for cognitive deficits in a progressive animal model for Parkinson's disease.
Leão AHFF; Meurer YSR; Freitas TA; Medeiros AM; Abílio VC; Izídio GS; Conceição IM; Ribeiro AM; Silva RH
Behav Brain Res; 2021 Jul; 410():113349. PubMed ID: 33971246
[TBL] [Abstract][Full Text] [Related]
5. Physical exercise improves motor and short-term social memory deficits in reserpinized rats.
Aguiar AS; Araújo AL; da-Cunha TR; Speck AE; Ignácio ZM; De-Mello N; Prediger RD
Brain Res Bull; 2009 Aug; 79(6):452-7. PubMed ID: 19463920
[TBL] [Abstract][Full Text] [Related]
6. Exposure to an enriched environment facilitates motor recovery and prevents short-term memory impairment and reduction of striatal BDNF in a progressive pharmacological model of parkinsonism in mice.
Campêlo CLC; Santos JR; Silva AF; Dierschnabel AL; Pontes A; Cavalcante JS; Ribeiro AM; Silva RH
Behav Brain Res; 2017 Jun; 328():138-148. PubMed ID: 28432010
[TBL] [Abstract][Full Text] [Related]
7. Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease.
Segovia G; Mora F; Crossman AR; Brotchie JM
Mov Disord; 2003 Feb; 18(2):138-49. PubMed ID: 12539206
[TBL] [Abstract][Full Text] [Related]
8. Acute treatment with bis selenide, an organic compound containing the trace element selenium, prevents memory deficits induced by reserpine in rats.
Bortolatto CF; Guerra Souza AC; Wilhelm EA; Nogueira CW
Biol Trace Elem Res; 2013 Jan; 151(1):92-9. PubMed ID: 23132249
[TBL] [Abstract][Full Text] [Related]
9. Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease.
Fernandes VS; Ribeiro AM; Melo TG; Godinho M; Barbosa FF; Medeiros DS; Munguba H; Silva RH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1479-83. PubMed ID: 18579275
[TBL] [Abstract][Full Text] [Related]
10. Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease.
Hille CJ; Fox SH; Maneuf YP; Crossman AR; Brotchie JM
Exp Neurol; 2001 Nov; 172(1):189-98. PubMed ID: 11681851
[TBL] [Abstract][Full Text] [Related]
11. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
[TBL] [Abstract][Full Text] [Related]
12. Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
Castro AA; Ghisoni K; Latini A; Quevedo J; Tasca CI; Prediger RD
Behav Brain Res; 2012 Apr; 229(1):208-15. PubMed ID: 22266923
[TBL] [Abstract][Full Text] [Related]
13. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the progressive model of parkinsonism induced by reserpine in rats.
Bispo JMM; Melo JEC; Gois AM; Leal PC; Lins LCRF; Souza MF; Medeiros KAAL; Ribeiro AM; Silva RH; Marchioro M; Santos JR
Behav Brain Res; 2019 May; 363():23-29. PubMed ID: 30690108
[TBL] [Abstract][Full Text] [Related]
15. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
Nehru B; Verma R; Khanna P; Sharma SK
Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
[TBL] [Abstract][Full Text] [Related]
16. A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
Johnston TH; Lee J; Gomez-Ramirez J; Fox SH; Brotchie JM
Exp Neurol; 2005 Feb; 191(2):243-50. PubMed ID: 15649479
[TBL] [Abstract][Full Text] [Related]
17. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Fleming SM; Delville Y; Schallert T
Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
[TBL] [Abstract][Full Text] [Related]
18. The effects of short-term nicotine administration on behavioral and oxidative stress deficiencies induced in a rat model of Parkinson's disease.
Ciobica A; Padurariu M; Hritcu L
Psychiatr Danub; 2012 Jun; 24(2):194-205. PubMed ID: 22706419
[TBL] [Abstract][Full Text] [Related]
19. Treatment with subthreshold doses of caffeine plus trihexyphenidyl fully restores locomotion and exploratory activity in reserpinized rats.
Moo-Puc RE; Villanueva-Toledo J; Arankowsky-Sandoval G; Alvarez-Cervera F; Góngora-Alfaro JL
Neurosci Lett; 2004 Sep; 367(3):327-31. PubMed ID: 15337259
[TBL] [Abstract][Full Text] [Related]
20. Reserpine-induced central effects: pharmacological evidence for the lack of central effects of reserpine methiodide.
Nammi S; Boini KM; Koppula S; Sreemantula S
Can J Physiol Pharmacol; 2005 Jun; 83(6):509-15. PubMed ID: 16049551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
